NRC Health (NRC)
NRC trades on Nasdaq in Health Care, Biotechnology: Commercial Physical & Biological Resarch. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$20.17
-1.18% on the day
Market cap
$446.2M
Small cap
Revenue · 2025
$137.4M
-4.0% on 2024
Net income · 2025
$11.6M
8.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | NRC on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000070487 |
| SEC industry code | Services-Commercial Physical & Biological Research |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $137.4M |
| Net income | $11.6M |
| Operating income | $22.6M |
| Net margin | 8.4% |
| Operating margin | 16.4% |
| Revenue growth | -4.0% |
| Cash | $4.1M |
| Total assets | $134.9M |
| P/E (computed) | 38.5× |
| P/S (computed) | 3.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B7 | 424B7 | 2026-05-13 |
| Latest annual report FORM 10-K/A | 10-K/A | 2026-04-28 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-04 |
| Latest current report FORM 8-K | 8-K | 2026-08-11 |
| Latest proxy FORM DEFA14A | DEFA14A | 2026-05-08 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +0.8% |
| 1 month | -7.3% |
| 3 months | -7.2% |
| Year to date | +8.5% |
| 1 year | +77.4% |
| From 52-week high | -10.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Commercial Physical & Biological Resarch
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| OABI | OmniAb Inc. | $4.70 | -1.47% | $683.3M |
| ABSI | Absci Corporation | $9.10 | -5.89% | $1.6B |
| MXCT | MaxCyte Inc. | $0.9643 | -3.08% | $99.5M |
| ONMD | OneMedNet Corp | $4.02 | +2.29% | $24.2M |
| ICLR | ICON plc | $164.34 | -0.04% | $12.6B |
| CRL | Charles River Laboratories International Inc. | $299.02 | -0.94% | $14.3B |
| MEDP | Medpace Holdings Inc. | $609.89 | -1.64% | $17.0B |
| INCY | Incyte Corp. | $108.62 | -2.46% | $22.0B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier